Dr. Glaser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Central St
Evanston, IL 60201Phone+1 847-503-3000Fax+1 847-503-3500
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Urology, 2012 - 2018- Northwestern University The Feinberg School of MedicineClass of 2012
Colgate UniversityBS, Molecular Biology, Summa Cum Laude, 2004 - 2008
Certifications & Licensure
IL State Medical License 2015 - 2026- American Board of Urology Urology
Clinical Trials
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) Start of enrollment: 2019 Mar 26
- Double-J PLUS Postmarket Registry Start of enrollment: 2020 Feb 19
- LURN: Urinary Urgency Phenotyping Protocol Start of enrollment: 2021 Feb 17
- Join now to see all
Publications & Presentations
PubMed
- 73 citationsAPOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.Alexander P. Glaser, Damiano Fantini, Yiduo Wang, Yanni Yu, Kalen Rimar
Oncotarget. 2018-01-12 - 86 citationsThe evolving genomic landscape of urothelial carcinomaAlexander P. Glaser, Damiano Fantini, Ali Shilatifard, Edward M. Schaeffer, Joshua J. Meeks
Nature Reviews. Urology. 2017-04-01 - 32 citationsTNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.Renee E Vickman, LaTayia Aaron-Brooks, Renyuan Zhang, Nadia A Lanman, Brittany Lapin
Nature Communications. 2022-04-19
Journal Articles
- Off-clamp robotically-assisted partial nephrectomy in polycystic kidney diseaseGlaser AP, Soares RM, Nadler RB, Videourology, 5/31/2018
Press Mentions
Northwestern Medicine PpoJuly 28th, 2020
Grant Support
- Effects of TNF Blockade on Human BPH/LUTSNIH/NIDDK2023–2028
- Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported OutcomesNIH/NIDDK2022–2027
- LURN II: Enhanced Characterization of Patients with LUTS using Biopsychosocial ApproachesNIH/NIDDK2012–2024
Professional Memberships
- Member
- Society of Urologic Oncology Clinical Trials ConsortiumMember
- Society of Benign Prostate DiseaseMember
Industry Relationships
- Consultant, Procept Biorobotics2023 - Present
External Links
- ResearchGatehttps://www.researchgate.net/profile/Alexander_Glaser2
- ORCiDhttps://orcid.org/0000-0003-1781-9023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
